Pre-treatment EGFR mutation analysis predicts clinical outcome in a retrospective analysis of 24 non-squamous non-small-cell lung cancer (NSCLC) patients treated with second line afatinib.

Anthonie J. Wekken, van der, Justine L. Kuiper, Danielle A. M. Heideman, Ed Schuuring, Wim Timens, Erik Thunnissen, Harry J. M. Groen, Egbert F. Smit

OnderzoeksoutputAcademic

Originele taal-2English
Pagina's (van-tot)3526
TijdschriftCancer Research
Volume73
Nummer van het tijdschrift8
DOI's
StatusPublished - 15-apr.-2013
Evenement104th Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Washington, Washington, United States
Duur: 6-apr.-201310-apr.-2013

Citeer dit